› Forums › Cutaneous Melanoma Community › President Carter’s melanoma diagnosis
- This topic has 33 replies, 8 voices, and was last updated 9 years, 4 months ago by Squash.
- Post
-
- August 20, 2015 at 8:32 pm
I write for the blog Addicting Info. Today I had a chance to educate our readers on melanoma, and that it's not just a minor skin condition, which is how some people seem to regard it.
http://www.addictinginfo.org/2015/08/20/jimmy-carter-has-melanoma-no-its-not-just-skin-cancer-video/
- Replies
-
-
- August 20, 2015 at 9:00 pm
One quick note: When I wrote this, I was working from President Carter's comments this morning, and I assumed he would get Yervoy. I guess a former president can jump the line and go right to Keytruda! lol
-
- August 20, 2015 at 9:20 pm
Thanks for posting about this Bill. I have heard that some Oncologist are going right to Pd-1 drugs even though it is not the standard of care. Maybe this event will push the FDA and Insurance companies in the right direction. It was interesting listening to the different news feeds asking their medical experts to talk about Melanoma and what President Carter's treatments will be like. Many had no clue about side effects and what to expect from Keytruda. ED
-
- August 20, 2015 at 9:44 pm
My understanding is that the FDA is going to rule on making the PD-1's first line treatment by sometime this fall, if not sooner.
I'd say it's a no brainer. Dr. Sharfman told me last fall that the PD-1 drugs held the most promise, but they were restricted to using Yervoy first.
My experience with Yervoy was mixed. It apparently stopped a lesion in my lung, but after I finished treatment, several new spots appeared under my skin near the original excision. So my doctor started me on Keytruda. Within two weeks after the first treatment, those spots were noticeably softer and thinner. I've had two treatments now, and I'm hopiing for more good news when I have my next scan, sometime next month.
The sooner Keytruda and Opdivo are approved as first line treatments, the better!
-
- August 20, 2015 at 9:44 pm
My understanding is that the FDA is going to rule on making the PD-1's first line treatment by sometime this fall, if not sooner.
I'd say it's a no brainer. Dr. Sharfman told me last fall that the PD-1 drugs held the most promise, but they were restricted to using Yervoy first.
My experience with Yervoy was mixed. It apparently stopped a lesion in my lung, but after I finished treatment, several new spots appeared under my skin near the original excision. So my doctor started me on Keytruda. Within two weeks after the first treatment, those spots were noticeably softer and thinner. I've had two treatments now, and I'm hopiing for more good news when I have my next scan, sometime next month.
The sooner Keytruda and Opdivo are approved as first line treatments, the better!
-
- August 20, 2015 at 9:44 pm
My understanding is that the FDA is going to rule on making the PD-1's first line treatment by sometime this fall, if not sooner.
I'd say it's a no brainer. Dr. Sharfman told me last fall that the PD-1 drugs held the most promise, but they were restricted to using Yervoy first.
My experience with Yervoy was mixed. It apparently stopped a lesion in my lung, but after I finished treatment, several new spots appeared under my skin near the original excision. So my doctor started me on Keytruda. Within two weeks after the first treatment, those spots were noticeably softer and thinner. I've had two treatments now, and I'm hopiing for more good news when I have my next scan, sometime next month.
The sooner Keytruda and Opdivo are approved as first line treatments, the better!
-
- August 20, 2015 at 9:20 pm
Thanks for posting about this Bill. I have heard that some Oncologist are going right to Pd-1 drugs even though it is not the standard of care. Maybe this event will push the FDA and Insurance companies in the right direction. It was interesting listening to the different news feeds asking their medical experts to talk about Melanoma and what President Carter's treatments will be like. Many had no clue about side effects and what to expect from Keytruda. ED
-
- August 20, 2015 at 9:20 pm
Thanks for posting about this Bill. I have heard that some Oncologist are going right to Pd-1 drugs even though it is not the standard of care. Maybe this event will push the FDA and Insurance companies in the right direction. It was interesting listening to the different news feeds asking their medical experts to talk about Melanoma and what President Carter's treatments will be like. Many had no clue about side effects and what to expect from Keytruda. ED
-
- August 20, 2015 at 9:21 pm
Thank you! I have felt sad since hearing the news about President Carter. Thank you for educating the public …on this illness. We have much to learn!
-
- August 20, 2015 at 9:21 pm
Thank you! I have felt sad since hearing the news about President Carter. Thank you for educating the public …on this illness. We have much to learn!
-
- August 20, 2015 at 9:21 pm
Thank you! I have felt sad since hearing the news about President Carter. Thank you for educating the public …on this illness. We have much to learn!
-
- August 23, 2015 at 11:16 pm
Mr. Saxde,
I'm not sure where you are getting your information, but anti-PD1 (no matter if you are talking nivo/opdivo, pembro/keytruda or the one still in trials) are NOT BRAF inhihitors. In fact, multiple studies show that folks respond to anti-PD1 in the same proportions regardless of BRAF status. There are many articles on my blog demonstrating the above. Best, Celeste
-
- August 23, 2015 at 11:16 pm
Mr. Saxde,
I'm not sure where you are getting your information, but anti-PD1 (no matter if you are talking nivo/opdivo, pembro/keytruda or the one still in trials) are NOT BRAF inhihitors. In fact, multiple studies show that folks respond to anti-PD1 in the same proportions regardless of BRAF status. There are many articles on my blog demonstrating the above. Best, Celeste
-
- August 23, 2015 at 11:16 pm
Mr. Saxde,
I'm not sure where you are getting your information, but anti-PD1 (no matter if you are talking nivo/opdivo, pembro/keytruda or the one still in trials) are NOT BRAF inhihitors. In fact, multiple studies show that folks respond to anti-PD1 in the same proportions regardless of BRAF status. There are many articles on my blog demonstrating the above. Best, Celeste
-
- August 21, 2015 at 4:51 am
Good on you, mrsaxde. We've had a few sportsmen (football players etc) in Australia get melanoma, and its been downplayed in the media as a 'brush with skin cancer'. One doc came out to say same as you, that melanoma is never just a 'brush with skin cancer' or 'just' skin cancer and the media should never use this kind of language or it will give people a false sense of security about just how serious it can be.
-
- August 21, 2015 at 4:51 am
Good on you, mrsaxde. We've had a few sportsmen (football players etc) in Australia get melanoma, and its been downplayed in the media as a 'brush with skin cancer'. One doc came out to say same as you, that melanoma is never just a 'brush with skin cancer' or 'just' skin cancer and the media should never use this kind of language or it will give people a false sense of security about just how serious it can be.
-
- August 21, 2015 at 4:51 am
Good on you, mrsaxde. We've had a few sportsmen (football players etc) in Australia get melanoma, and its been downplayed in the media as a 'brush with skin cancer'. One doc came out to say same as you, that melanoma is never just a 'brush with skin cancer' or 'just' skin cancer and the media should never use this kind of language or it will give people a false sense of security about just how serious it can be.
-
Tagged: cutaneous melanoma
- You must be logged in to reply to this topic.